Theravance Biopharma Inc（TBPH）价格预测TBPHTheravance Biopharma Inc

Alphio's TBPH stock price prediction model matches the current Theravance Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $17.47 (+2.59%). The 1-week path is $16.49 (-3.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Theravance Biopharma is currently a hold. The stock is trading at $17.02, which is very close to the acquisition price of $17.00 per share set by Zymeworks. The recent downgrade from Jones Trading reflects caution regarding the company's future performance, particularly after the acquisition announcement. Additionally, the RSI is at 41.36, indicating that the stock is neither overbought nor oversold, suggesting a neutral position. The main risk is the uncertainty surrounding the acquisition and the company's future earnings potential, especially after the CYPRESS trial did not meet its primary endpoint, which could impact future revenue streams.

Theravance Biopharma Inc (TBPH) last closed at $17.03, gaining +0.00%. These facts feed the 1-day and 1-week TBPH price prediction above.